Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.035 | 0.9 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |